Form 8-K - Current report:
SEC Accession No. 0001683168-22-001345
Filing Date
2022-03-01
Accepted
2022-02-28 20:50:34
Documents
12
Period of Report
2022-02-24
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pharmacyte_8k.htm   iXBRL 8-K 23877
  Complete submission text file 0001683168-22-001345.txt   196656

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE pmcb-20220224.xsd EX-101.SCH 3097
3 XBRL LABEL FILE pmcb-20220224_lab.xml EX-101.LAB 34476
4 XBRL PRESENTATION FILE pmcb-20220224_pre.xml EX-101.PRE 22599
6 EXTRACTED XBRL INSTANCE DOCUMENT pharmacyte_8k_htm.xml XML 3597
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

IRS No.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-40699 | Film No.: 22693290
SIC: 2836 Biological Products, (No Diagnostic Substances)